pepride fragments? Sure, would be nice to get a patent issued on that..but what good is it if RGRX has no money to do anything with it.. There hasn't been a single test or trial to show that the fragments do anything. It also depends on whwere RGRX sees the fragments going. If a prescribed anti wrinke thing, it will need FDA clinical trial & review.. But if they go OTC.you may not need FDA approval, but you still need to have something to show it works. RGRX has not done that yet, really. And if they go for OTC and perhaps try to license it out..since it is an OTC item, the upfront fee and royalty will not be minimal. There is also a risk of backlash if they ever suceed in TB 4 eyes and they try to charge $$ for it….but then payers see a similar peptide TB 4 fragment selling OTC for very little relatively. Fragmenst will help and a patent good….but it isn't going to save RGRX in tehe short to medium term. A trial in stroke done by Henry ford would give far more of a bounce to share price, vs a fragment peptide patent. But as usual, Finkel Dope is silent and hides what Henry ford may be planning - homan tral in stroke w/ TB 4. RGRX trades where it is largely because of Finkelstein. Zero confidence in mgmt.
Dope. Uncle Warren doesn't have to "get me out this". My basis in OB is over $2 below where we are now, and I've collected about a 5.5% dividend along the way. And with OB closing in on a hew high possibly….we are ar $16.30…..perhaps the nervous one is you.
Oh, shut up.
make all excuses you want for your supposed friend Finkel-Greedy- Dope. We have right to know if they applied for a grant. GEE! Maybe investors would like to know RGRX mgmt is DOING something? Just by saying you applied for one, doesn't mean that we all hold you to it, as a lock…. that you may or may not get it. That is the FDA's choice. But SILENCE kills..and Finkel Dope has no clue. Can you explain why Finkel Dop was all anxious to highlight a pre clinical test that Henry Ford did on mice in the heart area? Just a few weeks ago PR. But when the REAL specialists at Henry ford put out yet anpother neuro abstract in stroke…….where they say they got great result and they state they now have a mg/kg dose lined up for HUMAN trial…….RGRX is silent. Do you see a pattern here, B7? Or are you somehow blinded because Finkel Tinkel Dope maybe takes your call every now and then? WAKE UP. They guy is a complete 15 year FAILURE at RGRX. How on earth can you listen to him? Finkel Tinkel failed at the companies he was with before RGRX too.. Wake up. He is nothing but taking us foir a far too long free ride…..simply because he cannot be fired…..his wife is Dr' Goldstein's cousin.
I'm doing well in other stocks and haven't had the urge to buy more here, yet.. I do already own a lot of RGRX. The biggest holdback is not the money.…but the biggest issue with me is trusting FINKELSTEIN. He is probably a huge negative issue with a LOT of potential investors. His track record is C***…..if you buy more RGRX you are buying finkelstein. I'll probably find out if Henry Ford files for a human stroke trial, before Finkel Dope let's shareholders know. if Henry ford is doing the trial, at least the trial will be executed and designed correctly. i might buy on that. But I need to see that HENRY FORD IS DOING A TRIAL and how they design it. I might also buy if I track the FDA site closely and see that RGRX is awarded a $1.5 million grant for eye NK trial. Chances are we can find that out before Finkel Dope tells us.
Why would you think trial news from Henry Ford. Once again, RGRX and FINKEL DOPE are hiding things from shareholders. RGRX has said nothing about henry ford, even though all of us know that Henry Ford just finished a good pre clinical study recenty with TB 4 and that Henry Ford stated they have identified a TB 4 dose for a HUMAN TRIAL.in STROKES… So where is Finkel Tinkel on that? They did a PR release on the henry Ford heart trial…just recently? WHY does Finkel Dope hide that Henry ford has ANOTHER neuro/stroke abstract and they identified a dose for a HUMAN TRIALin STROKES..…which we assume they will do.
And why does Finkel Dope HIDE if he applied for FDA Orphan Grant…..RGRX announded they got Orphan STATUS…..why is he hiding if he applied for a GRANT? if Finkel Tinkel was more honest with shareholders, maybe we would not have been around 11 cents recently..Henry Ford stroke news..human trial dose news…and RGRX applying for ORPHAN GRANT..woudl have helped.…
There is logic to Buffet perhaps wanting WTM. A buyout of WTM also get's him 76% of OB shares and about 20% of all SYA shares. Buffet already owns 17 million SYA shares. WTM also owns 17 million SYA shares. If Buffet buys WTM, he goes to owning 34 million SYA, or about 40%….and 76% of OB. Since both SYA and OB woudl rise on a Buffet halo of he move on WTM….it is very logical that Buffet woudl buy as much SYA and OB as he could before.
BOTH SYA and OB have been unusually strong - and one way…up. Check out SYA today. But since Buffet owns so much SYA already..any buy of SYA shares by him would necessitate that he file a form 4 with the SEC 3 business days after any SYA purchase. So watch SYA. if you see Buffet increasing his SYA stake….it's a clue he is after something else too. But who knows what Buffert thinks. he might have no interest in WTM..but someone is buying WTM, OB and SYA.
I don't recall that any trial was "delayed". Lee's just took too long thinking about it. Lee's also had tio file with Chinese Gov't and I coudl see the Gov't taking a long time to review……there is a lot of corruption.Perhaps Lee's did not "pay"…so they were put on a one year review for a new trial befpre okay. A payment may have speeded it up. I don't see a real delay in Korea. They have n oidea what they are doing…..they've never touch bio stuff. So they fly blind as to the whole process. Korea is also kind of corrupt and need Gov't approvals.
As to "delay" in US eye NK trial? Finkel-Tinkel has NOT been honest on that. After he got Orphand Status for eye NK, the next logical step is to apply for ORPHAN GRANT. deadline was mid Feb……..decison by Oct…and first money in mid Nov. If Finkel-DOPE was HONEST with shareholders he would have stated that RGRX badly needs the FDA Orphan GRANT money to do eye NK trial. But since Finkel-Dope was NOt honest with you..you think that the eye NK trial is DELAYED for some other reason. not so. My bet is RGRX needs the Orphan grant and RGRX is asking FDA to go direct to a small phase 3 for eye NK. The PROCES of getting FDA Orphan Grant money takes almost 10 months. So if Finkel Tinkel had been honest with you, you woudl see it not as a delay, but the 10 month process..to get free money.
JBSAY shares trade more on soilid EBIDTA than net earnings…..because it is the EBIDTA number that pays the debt,,, and that will take a few years to pay down. but maybe less. JBS has said they want to do a IPO of JBS Foods of Brazil..and raise maybe $1 billion cash. That will go towards debt reduction. But both JBSAY and PPC are at or near highs on price. So I think the JBS and PPC are looking at the next deal, but to soothe bondholders and banks they will issue some equity….stock…in conjunction. I still say that SEB is the target. Possibly ALL of SEB…..which JBS would take the rest not including the pork and butterball, which JBS coudl take themselves. if not that, then just the Pork and Butterball to PPC.
I disagree that OB is too small for Buffet. You're right that Buffet probably wouldn't get OB as a single entity………but it could make sense that Buffet takes all of WTM and get's 75% stake in OB along the way. if you state that OB is too small for Buffet to own, then why does Buffet own 17 million shares of SYA?? humm? You also will notice that WTM also ownes 17 million shares of SYA. A buyout of WTM woudl give Buffet 34 million combined shares of SYA…….just under 40%?? And give him 76% control of OB……OB has some interesting new products that could expand VERY VERY fast, if they have the capital. - WHICH BUFFET DOES. I think OB's new Crop Insrance division would be attractive to Buffet. A huge market. His capital and his name……..it would grow extremely fast. Same goes for the Municipal Bond insurance investment WTM has thru BAM. That would also be very interesting to Buffet. WTM has a good reinsurance company, Sirius….WTM has numerous insurance related venture capital investments…WTM owns a $36 billion money manager…….White Mountain Advisors.
I think ALL of WTM would be of interest to Buffet…it is the SMALL pieces that WTM owns that would look good to him - combined…..and small pieces… from to BIG pieces. Buffet is VERY WELL AWARE that WTM took the GEICO competitor "Essurance" from nothing..to selling it to Allstate for $1 BILLION. Esurance competes directly with GEICO. So Buffet will not poo-poo ANY venture investments by WTM in the insurance area. WTM did very well. I think it is a BIG mistake to poo poo ANY investment idea for Buffet… if it is "too small". Again, WHY would Buffet own 17 million shares of SYA? Your thesis falls apart. Buffet SYA stake is worth a tiny $383 million. But you insist that is "too small" for Buffet? Then why does Buffet own SYA?
OB is acting very strong. Not sure what's up. Float is somewhat tight because WTM owns 75% and others hold OB fiorm because of the 5.4% dividend. Todays action, up, themn a whack fdown on Russia & Ukraine news.tanking overall market…..but teh buyer took in all in on way down then ran it right back up. Someone wants OB. Don't know if it is Buffet's style..but maybe. This new crop insurance division OB started is doing very well……..Buffet might like that area.
10-Q out. Few tidbits. Q2 20914 they spent $149,000 on R&D. That compares to $62,000 in Q2 2013. Wonder what the 149k was on?
They also said they are mwwting with FDA by end of 3rd Q to ask them to okay a phase 3 for eye NK trial. Interesting. BEing an orphan drug, it won't have to be a huge phs 3, but enough to satisfy FDA. RGRX made NO MENTION if they applied for an FDA Orphan Research Grant for the eye NK trial. That woudl be good for about $1.5 million over 3 years. First grants given in Nov, second in early 2015. So RGRX if they applied and get it…coudl get $800,000 pretty quickly. but as usual, RGRX is silent.
Also, RGRX said very little about Henry Ford or neuro. they said they may work with a major institution, if they have the money. but all RGRX has to do is supply TB4. RGRX is also hiding heh recent very good abstract from Henry ford where HF stated they have a dose targted for human trials. RGRX does NOT mention this or Henry Ford. Typical.
I think those shares that Koreans have right to buy at 15 cents would be newly issued shares directly from RGRX, not open market buys. Koreans are probably allowed to buy open market stock if they wish. Also, no reason for Koreans to think of exercising such a buy…yet. I'd wait till January 28 to decide if I wish to exercise an option right to buy 5.5 mill shares at .15.
I think it is very possible we will be above 0.15 come January…because hopefully RGRX will have started three eye trials. Hopefully RGRX will have received about $800,000 in an FDA Orphan Grant for an eye NK trial…..and hopefully, maybe…. Henry Ford comes out of the blue and says they are filing to do a small TB 4 trial in stroke Finkel Dope is very quiet on that…..I think both he, and henry ford, are waiting to make such announcent until the boondoggle Thymosin confab in Italy later this Fall.
See? It wasn't really a long seller puker today. Of all about 195k total volume, 113,600 shares was done as an opening SHORT position. Wasn't really tax loss sell this time, nor was it any insiders like Cavazzas selling…there was someone who bought….and the MM was very willing to short to them about 55% of all the volume today.
I do not believe the Cavazzas are selling any shars of RGRX. They own about 34% of RGRX. They have three business days to file with the SEC if they buy or sell any shares. That is the law. I do NOT think the Cavazzas would sell any shares and risk the ire of the SEC or US Gov't. Sigma Tau is a $1 biillion revenue company……and Sigma Tau has a VERY large US operation in Maryland..no way woudl they jeopardize the US operations by cheating the SEC on reportings some sales of a penny stock RGRX. Furthermore, RGRX would have to report shareholder stakes and it could get RGRX in trouble if they know a large reporting owner is selling and hiding it from the SEC.
We do not know if someone "dumped" 100,000 shares at 13 cents and change. How do you know it was not a SHORT, opening a position there? You don't….but we'll know later on today when FINRA reports. Not all large volume is automatically a long sell puke. But a lot of the early down draft to this area was a long seller.
I think that and JBS are seeing the numbers for Smithfield? Which is a better long term buy? I think PPC and JBS may think they were lucky not to get SFD. And they certainly know they weer smart not to pay $6.7 billion for Hillshire. Question is? WHO is left of the size, scale and distribution that would create huge efficiences in sales & marketing and manufacturing..for PPC? Only one answer. SEB's pork division and also their stake in Butterball. PPC overnight would become a leader (and really compete with TSN) in THREE..pork, chicken and turkey. I think that's just where PPC would like to be. They went to bat twice, for Smithfield and Hillshire. There is only one player left. SEB. That is my bet. if nothing happens in 4 months, I am wrong, but SEB's downside is nothing, compared to the possible upside. Bresky buys $53 million of SEB at $2,950. You don't think they'd buy more at $2,800? Downside risk is small. Just dream of 15 times EBIDTA and do the math. I see $100 to $150 downside, and up to $1,500 upside. Depends. But a 10-1 risk ratio.
Read these quotes from Smithfield release yesterday. Smithfield is signaling continued strength for quite a while. Earnings up 341%. I expect JBSAY to also surpass estimates:
"Net income +341% to second quarter record high of $142.9 million.
Market fundamentals continue to be supportive of our business on a number of fronts. Domestic protein demand is impressive. Although Russia has banned US pork imports, international demand from other countries remains strong. This, combined with lower domestic protein production, should support high hog and pork prices for the duration of 2014 and beyond. Notwithstanding a bullish hog production outlook, PEDv concerns seem to have thwarted market expansion for now. In addition, corn is currently trading at the lowest level in three years. This should translate into normalized fresh pork margins and high, above normalized hog production margins in 2014," said Mr. Pope.
I've been buying JBSAY when it ticks down a tad. All already know of it's extreme leverage. But JBS stated in June they plan an IPO in Brazil of subsidiary JBS foods which could raise $1 billion cash. That is deleveraging. Second point is that Smithfield reported earnings. They absolutely exploded for Smithfield. I expect they will also explode for JBSAY, because of the JBS America meat division. The third thing about the coming quarter (release on Aug 14)…..is that the WORLD CUP SOCCER was in Brazil - for almmost a MONTH. It was party time all over the world, and in particular party time in Brazil. What do people do? Cook and party or go out to bars & restaurants. Toursist flocked top Brazil. There has to be a big bump in JBS Brazil. I think earnigs soar at JBSAY…and they wiat till stock goes higher for IPO. combine that cash with possible $1 billion IPO soon, some debt buy down is near. Also, as JBSAY stock rises, I woudl expect that BOTH JBSAY and PPC will use shares as well as cash, in their next deal…which I expect to be SEB. The pork and 50% of Butterball is a no brainer for PPC……but what I wonder is if they might actually buy ALL of SEB in one fell swoop tender. PPC takes pork and turkey. JBS takes the container transport at ion, jalapeño ops and the huge sugar plantation. The Dominican power can be taken and sold later. The one sticker area if the African milling and grain businesses….they don't ever seem to do well, but people have to eat. JBSAY could issue stock for these SEB ops. JBS could offer stock and cash for butterball and pork. even with some dilution, I think PPC rise after becauise of 2 unique assets for PPC. IF JBS and PPC take ALL of SEB, it makes sense for SEB to pay down ALL debt now. Just have all cash, no debt. Easier to get bank financing that way.
I spotted in the proxy that McNAy controls 5.72 million shares……that is well more than double what Finkel Tinkel controls and almost double what Goldstein owns.
What the F has mcNay been doing here..being a Board member since the late 1980's. he had to have thought that he had been suckered somewhere along the line…..but McNAy stays on and even put MORE of his own money into it…but he is very well off I'm sure..so he doesn't have to worry about money After him being on the Board for about 26 YEARS….he, like us..wants to see how the story ends. All or none.
I'm not hyping there will be a deal for all WTM.I have no idea, but it rallied about $30 on something. If there ever was a deal for WTM, a buyer would pobably buy some shares before. But they would also probably be very smart and buy shares in One Beacon as well. WTM owns 75.3% of OB…and if ever someone wanted to buy all of WTM, it woudl make sense that they buy as much OB as they can ahead of time…to get their stake up as high as they can before a deal. OB came out with so-so earnings.but it is still a good company. On releasing the earnigs OB went down to $14.70. Merrill Lynch did their usual quarterly "put down" of OB..happens every quarter. So Merrill talked it down and poo-poos OB……but since Merrill did that……OB has rallied from $14.70 to now about $15.70. OB is kind of thin trading because WTM owns 75%. But if OB keeps going higher, in such a short time frame…..then that is a good clue that something could be up with WTM.